In the News

ACIP revises recommendations on hepatitis A vaccination

For postexposure prophylaxis, the hepatitis A vaccine is now preferred to immune globulin for all adults, including those older than 40 years of age, the Advisory Committee on Immunization Practices (ACIP) said.

Previous gastroenteritis may be associated with later risk for IBD

In this Swedish case-control study, any previous GI infection and previous bacterial, parasitic, and viral GI infection were associated with higher risk for inflammatory bowel disease (IBD) versus controls.

Halting one ulcerative colitis treatment after escalating to new drug may be feasible, study finds

Patients with ulcerative colitis treated with 5-aminosalicylates who require escalation to anti-tumor necrosis factor-alpha (anti-TNF) therapy may be able to safely discontinue the first drug.

MKSAP Quiz: New-onset ascites

This month's quiz asks readers to determine appropriate management for a 55-year-old man with hepatitis C-related cirrhosis who is hospitalized for new-onset ascites.

Spotlight on follow-up colonoscopy

One recent study identified four barriers to follow-up colonoscopy after a positive fecal-based test result, while another found that a delay of six months or more between a positive result and follow-up colonoscopy was associated with an increased risk of colorectal cancer.

FDA approves new drug for travelers' diarrhea

Compared to placebo, the drug significantly reduced symptoms in a randomized controlled trial of 264 adults with travelers' diarrhea in Guatemala and Mexico.

Incretin-based drugs not associated with any increase in risk for pancreatic diseases

The findings may reassure prescribers of dipeptidyl peptidase-4 inhibitors that the drug class does not significantly increase the risk of adverse pancreatic outcomes compared with other second-line therapies, study authors said.

In the Clinic: Nonalcoholic fatty liver disease

This feature provides an evidence-based, clinically relevant overview of the diagnosis and treatment of nonalcoholic fatty liver disease.